Vaccine Development

QA-UK is working with GCC interests and global experts in this area to implement solutions in the GCC.

The US rapid vaccine programs are seen by experts as being at the forefront of the new biopharmaceutical revolution, which will cut the development time of drugs from the present 12-14 years to a more manageable few months or years.

The Label-Free systems promoted by QA-UK have been adopted by the leading vaccine programs in the world.

Rapid response to emerging threats – such as the coronavirus here on the Arabian peninsular – requires a complete re-think on how we combat these problems. QA-UK aims to be at the vanguard of this process.